Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps...
Vous n'êtes pas connecté
Maroc - Times of India - Life & Style - 13/12/2024 17:13
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps...
A lack of vitamin B2 makes tumour cells more susceptible to a unique form of cell death. This was discovered by researchers at the Rudolf Virchow...
Researchers have discovered that an existing drug could be the breakthrough cure for a condition impacting 30 million people in the US, which until...
Researchers have discovered that an existing drug could be the breakthrough cure for a condition impacting 30 million people in the US, which until...
TUESDAY, March 10, 2026 -- Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA)...
THURSDAY, March 12, 2026 -- Less than 25 percent of adults with overweight or obesity without diabetes remain on any glucagon-like peptide-1 receptor...
Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily...
The results suggest that the five-year risk of major cardiovascular events such as heart attacks and the risk of end-stage kidney disease were reduced...
FRIDAY, March 13, 2026 -- For patients with cancer and brain metastases (BM) and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist...
MONDAY, March 23, 2026 -- Periconceptional exposure to glucagon-like peptide-1 (GLP-1) receptor agonists is associated with increased odds of preterm...